ChromaDex (NASDAQ:CDXC) Stock Rating Upgraded by Zacks Investment Research
ChromaDex (NASDAQ:CDXC – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Monday, Zacks.com reports. According to Zacks, “ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary […]
United States New Zealand Robertn Fried Zacks Investment Research Chromadex Corporation Advisor Group Holdings Inc
Source: etfdailynews.com